| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |